Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Turner Syndrome | 7 | 2023 | 8 | 5.270 |
Why?
|
| Menorrhagia | 3 | 2024 | 4 | 2.350 |
Why?
|
| Female | 20 | 2024 | 3362 | 1.680 |
Why?
|
| Humans | 22 | 2024 | 6579 | 1.420 |
Why?
|
| Ovarian Neoplasms | 2 | 2022 | 134 | 1.410 |
Why?
|
| Adolescent | 12 | 2024 | 2078 | 1.330 |
Why?
|
| Gynecology | 2 | 2024 | 4 | 1.090 |
Why?
|
| Child | 14 | 2024 | 3193 | 1.050 |
Why?
|
| Gonadoblastoma | 2 | 2022 | 2 | 1.030 |
Why?
|
| von Willebrand Diseases | 2 | 2022 | 4 | 1.000 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2024 | 2 | 0.970 |
Why?
|
| Joint Instability | 1 | 2024 | 3 | 0.970 |
Why?
|
| Vulvodynia | 1 | 2023 | 1 | 0.930 |
Why?
|
| Botulinum Toxins | 1 | 2023 | 8 | 0.910 |
Why?
|
| Vulvar Diseases | 2 | 2023 | 3 | 0.910 |
Why?
|
| Young Adult | 6 | 2023 | 616 | 0.880 |
Why?
|
| Blood Platelet Disorders | 1 | 2022 | 1 | 0.870 |
Why?
|
| Postpartum Hemorrhage | 1 | 2022 | 1 | 0.870 |
Why?
|
| Chromosome Disorders | 1 | 2022 | 7 | 0.870 |
Why?
|
| Menstruation Disturbances | 2 | 2019 | 2 | 0.850 |
Why?
|
| Graft vs Host Disease | 1 | 2022 | 12 | 0.850 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2022 | 4 | 0.850 |
Why?
|
| Infertility | 1 | 2022 | 2 | 0.850 |
Why?
|
| Fertility Preservation | 1 | 2022 | 6 | 0.840 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 52 | 0.800 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2021 | 14 | 0.780 |
Why?
|
| Pregnancy | 4 | 2022 | 188 | 0.760 |
Why?
|
| Retrospective Studies | 7 | 2023 | 1278 | 0.740 |
Why?
|
| Dysgerminoma | 1 | 2019 | 1 | 0.710 |
Why?
|
| Hymen | 1 | 2019 | 1 | 0.700 |
Why?
|
| Colpotomy | 1 | 2019 | 1 | 0.700 |
Why?
|
| Estrogens | 1 | 2018 | 3 | 0.670 |
Why?
|
| Tissue Adhesions | 1 | 2018 | 7 | 0.670 |
Why?
|
| Quality of Life | 3 | 2024 | 135 | 0.630 |
Why?
|
| Endometriosis | 1 | 2017 | 4 | 0.620 |
Why?
|
| Genitalia | 1 | 2017 | 3 | 0.620 |
Why?
|
| Operating Rooms | 1 | 2017 | 6 | 0.620 |
Why?
|
| Postoperative Complications | 1 | 2019 | 194 | 0.620 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 36 | 0.590 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 124 | 0.550 |
Why?
|
| Menstruation | 1 | 2015 | 4 | 0.520 |
Why?
|
| Blood Coagulation Disorders | 1 | 2015 | 8 | 0.520 |
Why?
|
| Infant | 4 | 2023 | 1394 | 0.420 |
Why?
|
| Child, Preschool | 4 | 2023 | 1476 | 0.420 |
Why?
|
| Castration | 2 | 2022 | 2 | 0.390 |
Why?
|
| Treatment Outcome | 2 | 2023 | 633 | 0.330 |
Why?
|
| Infant, Newborn | 2 | 2022 | 785 | 0.310 |
Why?
|
| Dermatology | 2 | 2024 | 3 | 0.300 |
Why?
|
| Vulvar Lichen Sclerosus | 2 | 2024 | 3 | 0.300 |
Why?
|
| Lichen Sclerosus et Atrophicus | 2 | 2024 | 3 | 0.300 |
Why?
|
| Anti-Mullerian Hormone | 2 | 2023 | 2 | 0.270 |
Why?
|
| Vitiligo | 1 | 2023 | 1 | 0.240 |
Why?
|
| Vulvitis | 1 | 2023 | 1 | 0.240 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 28 | 0.230 |
Why?
|
| Registries | 1 | 2023 | 86 | 0.230 |
Why?
|
| Hormone Replacement Therapy | 1 | 2023 | 1 | 0.230 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2024 | 81 | 0.230 |
Why?
|
| Estradiol | 1 | 2023 | 9 | 0.230 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 34 | 0.230 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2022 | 2 | 0.220 |
Why?
|
| Prenatal Diagnosis | 1 | 2022 | 14 | 0.220 |
Why?
|
| HLA Antigens | 1 | 2022 | 13 | 0.210 |
Why?
|
| Placenta | 1 | 2022 | 23 | 0.210 |
Why?
|
| Chromosomes, Human, Y | 1 | 2022 | 1 | 0.210 |
Why?
|
| Fertility | 1 | 2022 | 8 | 0.210 |
Why?
|
| Mosaicism | 1 | 2022 | 9 | 0.210 |
Why?
|
| Homosexuality, Female | 1 | 2022 | 1 | 0.210 |
Why?
|
| Ovarian Reserve | 1 | 2022 | 1 | 0.210 |
Why?
|
| Cryptorchidism | 1 | 2022 | 9 | 0.210 |
Why?
|
| Incidence | 1 | 2022 | 128 | 0.210 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2021 | 10 | 0.200 |
Why?
|
| Congenital Abnormalities | 1 | 2019 | 13 | 0.170 |
Why?
|
| Suture Techniques | 1 | 2019 | 11 | 0.170 |
Why?
|
| Postoperative Care | 1 | 2019 | 29 | 0.170 |
Why?
|
| Emollients | 1 | 2018 | 2 | 0.170 |
Why?
|
| Administration, Topical | 1 | 2018 | 6 | 0.170 |
Why?
|
| Recurrence | 1 | 2018 | 119 | 0.160 |
Why?
|
| Adult | 1 | 2022 | 1139 | 0.160 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 144 | 0.160 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2017 | 1 | 0.160 |
Why?
|
| Pelvic Pain | 1 | 2017 | 1 | 0.160 |
Why?
|
| Contraceptives, Oral | 1 | 2017 | 3 | 0.160 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 312 | 0.150 |
Why?
|
| Factor VII Deficiency | 1 | 2017 | 3 | 0.150 |
Why?
|
| Genitalia, Female | 1 | 2017 | 4 | 0.150 |
Why?
|
| Cohort Studies | 1 | 2017 | 262 | 0.140 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 178 | 0.140 |
Why?
|
| Hormones | 1 | 2015 | 3 | 0.130 |
Why?
|
| Menarche | 1 | 2015 | 4 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2017 | 217 | 0.130 |
Why?
|
| Prevalence | 1 | 2015 | 146 | 0.130 |
Why?
|
| Male | 3 | 2024 | 3113 | 0.100 |
Why?
|
| Gonadotropins | 1 | 2023 | 4 | 0.060 |
Why?
|
| Puberty | 1 | 2023 | 6 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 96 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 262 | 0.050 |
Why?
|
| Sexual Maturation | 1 | 2022 | 2 | 0.050 |
Why?
|
| Gonads | 1 | 2022 | 2 | 0.050 |
Why?
|
| Contraceptive Agents | 1 | 2022 | 13 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 2022 | 34 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2023 | 520 | 0.050 |
Why?
|
| Child Development | 1 | 2022 | 42 | 0.050 |
Why?
|